Find Academic Supervisors

CEMİL AYDOĞANView profile

Professor

• Analytical Chemistry
• Separation Science
• Nano-Liquid Chromatography
• +5 more

Professor Cemil Aydoğan serves as a full Professor in the Faculty of Engineering and Architecture at Bingol University since 2023, following promotions from Associate Professor (2017-2023) and Assistant Professor (2014-2017). His academic journey includes a postdoctoral position at Oklahoma State University (2014-2015) and research assistantships at Hacettepe University in Chemistry and Pharmaceutical Sciences. Current institutional affiliations include editorial roles as Guest Editor for Molecules , Topic Editor for Frontiers in Chemistry , and Handling Editor for BMC Chemistry . His research focuses on advancing nano-liquid chromatography and capillary electrochromatography techniques, particularly through innovative monolithic stationary phases incorporating nanomaterials like graphene oxide and fumed silica. Key application areas include: Chiral separation of pharmaceutical compounds and biomarkers Proteomics analysis for food authentication (honey, milk, pistachios) Development of specialized columns for exosome analysis and antibiotic residue detection Integration of nano-LC with high-resolution mass spectrometry for complex sample analysis Professor Aydoğan's scientific contributions are recognized through three major awards and extensive service as a referee for over 40 analytical chemistry journals. His funding profile includes research grants supporting international collaboration and conference participation, with recent projects focusing on foodomics and pharmaceutical analysis. He maintains active supervision of graduate students, with three Master's theses completed between 2019-2024 focusing on nano-LC applications in food analysis. His laboratory capabilities center on custom monolithic column fabrication, nano-LC system optimization, and advanced data analysis for separation science.

• Clinical Pharmacology
• Biomarker Identification and Validation
• Metabolism in Disease States
• +3 more

Dr. Trey Putnam serves as Full Professor in the Department of Pharmaceutical Sciences and Department of Pharmacy Practice at Texas Tech University Health Sciences Center (TTUHSC) School of Pharmacy, and directs the Clinical Pharmacology and Experimental Therapeutics Center since 2017. His dual appointments reflect his interdisciplinary expertise spanning pharmacological sciences and clinical practice. Dr. Putnam earned his BS in Chemistry from Pittsburg State University (1995), followed by MA (1997) and PhD (1999) in Organic Chemistry from Washington University in St. Louis under Prof. James K. Bashkin. His doctoral research focused on artificial ribonucleases for infectious disease therapy. Additional training included NSF-funded undergraduate research in X-ray crystallography at the University of Oklahoma. His research program centers on clinical pharmacology in special populations (pediatrics, obesity), biomarker validation, disease-state metabolism alterations, and advanced analytical methodologies. With deep expertise in organic, analytical, and bioanalytical chemistry, he bridges drug discovery with clinical translation. His work addresses critical gaps in therapeutic optimization across diverse patient populations, integrating regulatory science perspectives from his industry experience. Analysis of his 2018-2024 publications reveals consistent focus on clinical pharmacokinetics, biomarker development, and therapeutic applications in oncology, infectious diseases, and metabolic disorders. His collaborative studies frequently employ mass spectrometry-based analytical methods to solve real-world dosing challenges, particularly in complex disease states and special populations. Dr. Putnam has secured funding as Principal Investigator or co-Investigator from NIH, industry partners, and university sources. He leads the Clinical Pharmacology and Experimental Therapeutics Center, which provides infrastructure for translational pharmacology research including bioanalytical services, clinical trial design support, and biomarker validation studies.

Abdul K. MohammedView profile

Professor

• Environmental Chemistry
• Bioinorganic Chemistry
• Photochemistry
• +1 more

Dr. Abdul K. Mohammed serves as Professor and Chair of the Department of Chemistry and Biochemistry at North Carolina Central University's College of Science and Technology, having previously held leadership roles as Dean of the same college and Chair of Chemistry at Winston Salem State University. His academic foundation includes: B.Sc. in Chemistry from University of Benin, Nigeria (1983) Ph.D. in Inorganic Chemistry from Louisiana State University (1992) Postdoctoral Research at Florida State University (1992-1993) His research integrates Environmental Chemistry through semiconductor-assisted photodegradation of water pollutants, Bioinorganic Chemistry via transition-metal complexes as antineoplastic agents, and Photochemistry of metal complexes. He pioneers Chemical Education innovations with student-centered pedagogies at HBCUs. Publication analysis reveals a consistent trajectory from foundational photochemistry (1990s) to applied environmental remediation (2005-2014), culminating in recent nanomaterial-focused wastewater solutions (2019-2021). Over 60% of his work addresses environmental applications, particularly photocatalytic pollutant degradation using TiO2/ZnO systems. His scholarly recognition includes: Fulbright Scholar award for research at Sultan Qaboos University, Oman (2003-2004) Carnegie African Diaspora Fellowship for collaborations in Nigeria (2017, 2019) As principal investigator for the NCCU-UNC Master's to Ph.D. Chemistry Bridge Program, he develops pathways for underrepresented students. His mentorship is evidenced by 12+ student co-authored publications since 2009, particularly in chemical education and environmental analysis projects. His research team collaborates internationally on wastewater treatment technologies and maintains active partnerships with UNC Chapel Hill through the Chemistry Bridge Program, focusing on nanomaterial synthesis and environmental applications.

Lucien BaldasView profile

Professor

• Microfluidics
• Gas Microflows
• Fluidic Micro-actuators
• +4 more

Lucien Baldas is a Professor in the Mechanical Engineering Department at the National Institute of Applied Sciences of Toulouse (INSA Toulouse), where he serves as Associate Dean since 2020 and previously held roles including Director for International Relations (2007-2013). He is a member of the Modeling of Mechanical Systems and Microsystems (MS2M) research group, focusing on microfluidics and gas dynamics. His research spans microfluidics , gas microflows , fluidic micro-actuators for active flow control , particle-laden flows in microchannels , and mini pneumatic systems . Key projects include coordination of the ANR/DFG Project PuCK (2023-2026), Work-Package leadership for European Projects PERSEUS and MACAO, and coordination of the MIGRATE Training Network. His work demonstrates strong integration of theoretical modeling with experimental validation across fluid dynamics applications. Analysis of his 125+ publications reveals consistent focus on microscale flow phenomena , thermal effects in gas flows , and fluidic actuator development . Recent work (2021-2025) emphasizes additive manufacturing for microsystems , high-frequency fluidic oscillators , and multi-physics integration in microfluidic devices, with significant contributions to rarefied gas dynamics and particle transport phenomena. Key Administrative Roles: Associate Dean of Mechanical Engineering Department (2020-present) Elected Board of Studies member (2022-present) Co-chair of ISTEGIM 2019 Symposium Work-Package leader for multiple EU projects Co-Leader of Microfluidics Working Group (since 1999) His teaching portfolio includes Solid Mechanics, Automatic Control, Fluid Mechanics, and Computational Fluid Dynamics at INSA Toulouse. He has supervised numerous PhD students through EU projects and coordinates international research collaborations across Europe and North America.

• Bioinorganic Chemistry
• Medicinal Inorganic Chemistry
• Supramolecular Chemistry
• +6 more

Professor Christian Hartinger is a distinguished academic in the Faculty of Science at the University of Auckland, where he serves as a Professor in the Chemical Sciences department. With over two decades of research experience, he leads an internationally recognized research group focused on bioinorganic chemistry and medicinal inorganic chemistry. His academic journey spans institutions including the University of Vienna, EPFL in Switzerland, and the University of Auckland, where he has been faculty since 2011. Professor Hartinger completed his Mag. rer. nat. (MSc) at the University of Vienna in 1999, followed by his Dr. rer. nat. (PhD) in Chemistry in 2001 under Bernhard Keppler. After research at the University of Vienna, he joined Paul Dyson's group at EPFL as a Schrödinger Fellow (2006-2008). He returned to Vienna to complete his habilitation in Inorganic Chemistry in 2009 before moving to New Zealand in 2011. His research spans the interdisciplinary area of bioinorganic chemistry, with a focus on the design of new metallodrugs built on organometallic scaffolds featuring bioactive ligand systems. Key areas include complexes of pyridinethiocarbamides, hydroxamic acids, flavonols, and maleimides. More recently, his group has developed interests in supramolecular chemistry, focusing on stimulus-responsive systems for drug delivery and catalysis. His analytical methodology development has contributed significantly to understanding metallodrug behavior in complex biological environments. Professor Hartinger's scientific achievements have been recognized with numerous prestigious awards: Society of Biological Inorganic Chemistry Early Career Award (2016) NZ Institute of Chemistry's Maurice Wilkins Centre Prize (2016) NZAS Hill Tinsley Medal (2017) Morrison Medal (2019) RACI Inorganic Division Burrows Award (2022) ISBOMC Award (2023) Humboldt Research Award (2024) Fellow of the Royal Society of New Zealand (2021) New Zealand Mana Tūārangi Distinguished Researcher Fellowship (2025-2027) As an accredited PhD supervisor, Professor Hartinger provides opportunities for graduate students in the development of anticancer metallodrugs and related analytical methodologies. His research group employs a highly interdisciplinary approach combining inorganic and organic synthesis, supramolecular chemistry, analytical chemistry, biology, pharmacy and medicine. The group's work has resulted in numerous high-impact publications in top journals and significant contributions to understanding the mechanisms of metallodrugs. Professor Hartinger's laboratory, the Hartinger Research Group, focuses on developing novel metallodrugs with multimodal/multitargeted properties and understanding their interactions with biological systems. The group has made significant contributions to identifying protein targets of anticancer ruthenium complexes and developing analytical methods to study metallodrug-protein interactions. Their recent work on stimulus-responsive supramolecular systems represents an exciting new direction in drug delivery applications.

Stig Pedersen-BjergaardView profile

Professor

• Analytical Chemistry
• Sample Preparation
• Microextraction
• +3 more

Stig Pedersen-Bjergaard holds dual academic appointments as a full-time Professor of Pharmacy/Drug Analysis at the University of Oslo (since 2000) and a part-time Professor (20%) in Analytical Chemistry at the Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen (since 2008). His research focuses on pioneering microextraction technologies for sustainable analytical chemistry. His academic credentials include: Master of Science (Chemistry), Technical University of Denmark, 1990 Doctor Scientiarum (Analytical Chemistry), University of Oslo, 1995 Professor Pedersen-Bjergaard's research centers on conceptual development of microextraction systems based on mass transfer across artificial liquid membranes, downscaled to nano- and microliter volumes. His group invented liquid-phase microextraction (LPME) and electromembrane extraction (EME), which provide green, selective sample preparation for next-generation analytical chemistry. Applications primarily target pharmacy and biomedicine using liquid chromatography-mass spectrometry, with recent commercialization of EME technology driving increased adoption. His 2024-2026 publications reveal strong trends toward electromembrane extraction optimization, green chemistry assessment, and high-throughput applications in pharmaceutical, food, and forensic analysis. Key subfields include nanomaterial-enhanced membranes, multi-class veterinary drug screening, and volumetric microsampling for blood analysis. He leads the Microscale Analytical Systems research group, operating the Drug Metabolism Lab at the University of Copenhagen in collaboration with the University of Oslo. His editorial roles include Trends in Analytical Chemistry , Advances in Sample Preparation , and Journal of Pharmaceutical Analysis , while his teaching covers bioanalytical sample preparation techniques.

• Clinical Pharmacology
• Geriatric Pharmacology
• Renal Function Assessment
• +3 more

Morten Baltzer Houlind is a Guest Researcher in the Department of Drug Design and Pharmacology at the University of Copenhagen, specializing in translational and clinical pharmacology. His work focuses on optimizing drug therapy for elderly patients through advanced renal function assessment and biomarker development. Dr. Houlind's research centers on geriatric pharmacology with emphasis on glomerular filtration rate (GFR) measurement techniques, biomarker validation (suPAR, NGAL, KIM-1, GDF-15), and cannabinoid pharmacokinetics in aging populations. His projects include developing dried blood spot testing protocols, improving medication review systems for acute hospital admissions, and conducting clinical trials on appetite stimulation therapies for elderly patients with poor appetite. Analysis of his recent publications reveals a cohesive research trajectory focused on precision dosing in geriatric care, integrating pharmacokinetic modeling with novel biomarker discovery to address renal impairment challenges. His work consistently targets practical clinical applications for vulnerable elderly populations, particularly in hospital settings where polypharmacy and renal dysfunction complicate treatment.

• Bioanalytical Chemistry
• Protein Analytical Chemistry
• Mass Spectrometry
• +7 more

Kasper Dyrberg Rand is a Professor and Group Leader of the Protein Analysis Group at the Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen. He has held this professorship since 2021, following his appointment as Professor MSO in 2017, Group Leader in 2012, and Associate Professor in 2011. Education: Ph.D. in Biochemistry, Protein Research Group, University of Southern Denmark (2007) MSc in Biochemistry, Department of Protein Chemistry, University of Copenhagen (2003) Professor Rand's research focuses on Bioanalytical Chemistry and Protein Analytical Chemistry, with particular expertise in analyzing protein primary structures using liquid chromatography and mass spectrometry (LC-MS), examining higher-order protein structures and molecular interactions through hydrogen/deuterium exchange mass spectrometry (HDX-MS), and developing microfluidic systems coupled to mass spectrometry. His work bridges analytical chemistry, biochemistry, and pharmaceutical sciences, with applications in biopharmaceutical development and characterization. His recent publications demonstrate a strong focus on advancing HDX-MS methodology, protein characterization techniques, and applications in antibody research, vaccine development, and biopharmaceutical analysis. The research spans analytical chemistry, structural biology, immunology, and glycobiology, with particular emphasis on developing novel analytical tools and approaches for protein characterization. Scientific Awards: ERC Consolidator Grant Investigator (2021-2026) Sapere Aude Research Leader of the Danish Research Councils (2016-2020) Industrial Doctorate Programme recipient from EU (2016-2020) Steno Fellowship from the Danish Research Council (2011-2015) Marie Curie Career Integration Award (2011-2015) Professor Rand has secured substantial research funding from diverse sources including the European Research Council, Danish Research Councils, EU Horizon programs, pharmaceutical companies, and foundations. He has served as main supervisor for over 13 PhD students and 25 Master's students, and has mentored 4 Postdocs and 2 Assistant Professors, demonstrating strong commitment to academic training and development. He leads the Protein Analysis Group within the Section of Analytical Biosciences at the Department of Pharmacy, University of Copenhagen, focusing on developing and applying advanced analytical techniques for protein characterization, particularly in the context of biopharmaceuticals and therapeutic proteins.

Stefan StürupView profile

Associate Professor

• Analytical Chemistry
• Pharmaceutical Analysis
• Isotope Ratio Analysis
• +5 more

Stefan Stürup is an Associate Professor in the Department of Pharmacy at the Faculty of Health Sciences, University of Copenhagen. His research focuses on advanced analytical chemistry applications for drug product characterization and identification of falsified/substandard pharmaceuticals. His primary research interests include: Application of isotope ratio analysis ($$\delta^{13}\text{C}$$, $$\delta^{2}\text{H}$$, $$\delta^{18}\text{O}$$, $$^{87}\text{Sr}/^{86}\text{Sr}$$, $$^{207}\text{Pb}/^{206}\text{Pb}$$) for drug characterization Trace element pattern analysis in pharmaceutical products ICP-MS/ICP-OES based instrumentation for trace elemental impurity determination Uptake and biotransformation of metal-based drugs Development of novel drug delivery vehicles including nanoparticles and metal complexes His recent research has focused on analyzing ibuprofen drug products, investigating isotopic patterns, trace elements, and impurities to ensure pharmaceutical quality and detect falsified products. He has also conducted significant research on metal-based drugs including platinum compounds and gold(I) complexes, examining their cellular distribution, toxicity mechanisms, and potential therapeutic applications. Dr. Stürup has supervised 7 PhD students and 34 master students, with recent projects focusing on isotope ratio analysis in pharmaceuticals and analytical method development. He teaches Pharmaceutical Analytical Chemistry and Kemiske Principper (Chemical Principles) at the bachelor's level. His professional activities include membership in COST actions focused on metal complexes and metallo-drug design, serving as a technical assessor for the Danish Accreditation and Metrology Fund (DANAK), and reviewing for 15 analytical chemistry journals since 1995. His work bridges analytical chemistry, pharmaceutical sciences, and toxicology with practical applications for drug quality control and therapeutic development.

Janina KneippView profile

Professor

• Surface-Enhanced Raman Scattering
• Plasmonic Catalysis
• Nanoscale Spectroscopy
• +4 more

Prof. Dr. Janina Kneipp is a Professor (W3) of Physical Chemistry at Humboldt-Universität zu Berlin, where she has led an active research group since 2012. She previously held positions as Assistant Professor at HU Berlin/BAM (2008-2012), Junior Researcher at BAM (2005-2008), and research appointments at Harvard Medical School, Princeton University, and Erasmus Universiteit Rotterdam. Education: Dr. rer. nat. (summa cum laude), Freie Universität Berlin (2002) Undergraduate/Graduate Studies in Biology & Physics, Freie Universität Berlin (1992-1998) Research Focus: Her interdisciplinary work bridges physical chemistry and biospectroscopy, with particular emphasis on: Surface-enhanced Raman scattering (SERS) for complex sample analysis Plasmonic catalysis and hot electron chemistry Multiphoton-excited vibrational spectroscopy Nanoscale biochemical mapping in plant and animal systems Development of advanced plasmonic substrates Publication Trends: Recent work demonstrates strong focus on multimodal spectroscopy applications, with studies combining SERS, hyper-Raman, IR, and synchrotron techniques to address questions in catalysis, nanoparticle-cell interactions, plant biochemistry, and biosensing. Publications frequently incorporate advanced nanomaterials, electrochemical methods, and machine learning-assisted spectral analysis. Scientific Awards: Fellow, European Academy of Sciences (2020) Caroline von Humboldt Professorship (2019) Wilhelm Ostwald Fellow, BAM (2012) Bunsen-Kirchhoff Award, GDCh (2010) ERC Starting Grant (2010) Academic Leadership: Currently advises 5 PhD students and leads multiple collaborative initiatives. Serves as Board Member of Einstein Center Catalysis (since 2019), Head of Chemistry Department (2014-2016), and Speaker of Graduate School SALSA (since 2012). Secured funding through DFG, EU networks, and ERC grants supporting spectroscopy infrastructure development. Lab & Team: Leads the KneippLab research group with 2 postdoctoral researchers, 5 graduate students, and technical staff. Research focuses on developing spectroscopic methods for interrogating biological and chemical processes at nanoscale resolution using plasmonic enhancement strategies.

• Bioanalytical Chemistry
• Polymer-Biosystem Interactions
• Drug Development for Inflammatory Diseases
• +2 more

Dr. Jens Dernedde serves as Privatdozent (Private Lecturer) at Charité - University Medicine Berlin's Institute for Laboratory Medicine, Clinical Chemistry and Pathobiochemistry. He actively leads the Bioanalytical Core Unit within Collaborative Research Centers and participates in International Research Training Group GRK 2662 'Charging into the Future'. His research integrates bioanalytical chemistry with polymer science to investigate polyelectrolyte-biosystem interactions and multivalent binding phenomena. Key applications include preclinical development of dPGS-based therapeutics for chronic inflammatory diseases and analytical method standardization for quantifying biological interactions. Current projects focus on advancing polymer-biosystem interaction models through GRK 2662's international framework while maintaining analytical leadership via the Bioanalytical Core Unit. This work supports drug development pipelines and fundamental understanding of biomolecular interactions. Dr. Dernedde's lab provides specialized training in bioanalytical techniques for characterizing complex biological interactions, with strong connections to Collaborative Research Centers and international training networks. The Bioanalytical Core Unit serves as central infrastructure for multiple research groups studying multivalent systems.

• Proteomics
• Metabolomics
• Lipidomics
• +4 more

PD Dr. Jörg Reinders serves as Head of the Scientific Central Unit Bioanalytics at the Leibniz Research Centre for Working Environment and Human Factors (IfADo) at TU Dortmund University. His position places him within the Toxicology department where he leads research in advanced analytical techniques for biological systems, contributing significantly to the institute's mission of investigating work environments and human health. Dr. Reinders' educational background includes: Diploma in Biochemistry from Ruhr-University Bochum (2002) PhD (Dr. rer. nat.) from Julius-Maximilians-University Wuerzburg (2006) Habilitation in "Functional Genomics" from University Regensburg (2013) His research focuses on cutting-edge bioanalytical techniques with emphasis on proteomics, metabolomics, and lipidomics . Dr. Reinders develops and applies advanced analytical methods to study complex biological systems, particularly in the context of toxicology and human health. His work bridges analytical chemistry with biological applications, enabling deeper understanding of molecular mechanisms in health and disease. Recent publications demonstrate a strong focus on toxicology, molecular mechanisms of disease, and biomarker discovery . His research spans multiple systems including liver function, neurotoxicology, and cancer biology. Notably, his work often involves cross-disciplinary collaboration, combining analytical expertise with clinical and biological insights to address complex health questions. As Head of Bioanalytics, Dr. Reinders oversees a scientific central unit providing advanced analytical services and developing novel methodologies. His team supports multiple research groups at IfADo with state-of-the-art proteomic, metabolomic, and lipidomic analyses, contributing significantly to the institute's research output in occupational and environmental health.

• Lung Cancer
• Oncology
• Respiratory Medicine
• +5 more

Hirsh Koyi is a Researcher affiliated with Uppsala University through the Centre for Research & Development at Region Gävleborg, focusing on clinical oncology and respiratory medicine. His work bridges hospital-based clinical research with academic investigation, primarily conducted at Gävle Hospital. His research spans lung cancer diagnostics, pleural effusion analysis, pharmacogenomics of chemotherapy toxicity, and swallowing dysfunction in respiratory diseases. Key interests include: Non-small cell lung cancer molecular subtyping and prognostic biomarkers Genetic variants influencing gemcitabine/carboplatin toxicity Dysphagia mechanisms in COPD and post-COVID recovery Ethnic disparities in mesothelioma and lung cancer outcomes His methodology integrates genomic analysis, clinical pharmacology, and patient-centered outcomes assessment. Recent publications demonstrate consistent focus on translational oncology, with trends toward personalized treatment prediction using gene expression and pharmacogenomic markers. His collaborative work frequently addresses real-world clinical challenges in elderly cancer patients and post-ICU rehabilitation. Koyi maintains active clinical research collaborations across Swedish medical centers, particularly in pharmacokinetic studies and respiratory complication management. His work appears in journals spanning oncology, respiratory medicine, and analytical pharmacology.

• Analytical Chemistry
• Environmental Toxicology
• Bioanalytical Technology
• +4 more

Dr. Chris Le is a Distinguished University Professor in the Department of Laboratory Medicine & Pathology at the Faculty of Medicine & Dentistry, University of Alberta. He serves as Director of the Analytical and Environmental Toxicology Division, where he leads research at the intersection of analytical chemistry, environmental health, and biomedical applications. Dr. Le's educational background includes: PhD (1993) in Chemistry from the University of British Columbia MSc (1988) in Chemistry from Brock University MSc (1986) from Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences BSc (1979) in Chemistry from Wuhan University Dr. Le's research focuses on developing novel analytical techniques for environmental contaminants and biomedical applications. His work spans multiple areas including arsenic speciation and toxicology, CRISPR-based detection systems, DNAzyme technology, and nanosystems for drug delivery. He has made significant contributions to understanding arsenic metabolism, developing sensitive detection methods for environmental contaminants, and creating innovative molecular diagnostic tools. His laboratory has pioneered techniques for the detection of nucleic acids, proteins, and environmental pollutants with applications in both environmental monitoring and clinical diagnostics. Analysis of Dr. Le's recent publications reveals a strong focus on CRISPR-Cas technology for molecular detection, particularly for viral pathogens including SARS-CoV-2 variants. His work bridges analytical chemistry with molecular biology to develop highly sensitive detection platforms. There's also a consistent thread of research on arsenic speciation, metabolism, and toxicity, demonstrating his longstanding expertise in environmental toxicology. His publications show interdisciplinary collaboration across chemistry, biology, environmental science, and clinical medicine. Dr. Le has received numerous prestigious awards and recognitions: Distinguished University Professor at the University of Alberta (2011) Fellow of the Royal Society of Canada (2010) Canada Research Chair (Tier 1) in Bioanalytical Technology and Environmental Health (2010-2017) Fellow of the Royal Society of Chemistry (UK) (2016) Martha Cook Piper Research Prize (2000) E.W.R. Steacie Memorial Fellowship from NSERC (2000) Multiple awards from the Canadian Society for Chemistry including the Maxxam Award and W.A.E. McBryde Medal Dr. Le actively mentors graduate students (MSc and PhD), undergraduate students, and post-doctoral fellows. His research has been supported by significant grants including the Canada Research Chair program and various research council funding. He serves on editorial boards for prestigious journals including Analytical Chemistry and Environmental Health Perspectives, demonstrating his leadership in the scientific community. As Director of the Analytical and Environmental Toxicology Division, Dr. Le leads a multidisciplinary team that combines expertise in analytical chemistry, molecular biology, and environmental health sciences. His laboratory develops cutting-edge technologies for environmental monitoring and clinical applications, with particular emphasis on translating basic research into practical solutions for public health challenges.